William Ackman
Bill Ackman runs hedge fund Pershing Square Capital, which he started in 2003 following the dissolution of Gotham Partners.
Ackman is a value investor with an activist bent. Activist investors agitate management for changes. He owns large positions in Target (NYSE: TGT) and Borders (NYSE: BGP). He has also been involved in activist situations at Wendy's (NYSE: WEN) and McDonald's (NYSE: MCD).
Ackman proved his acumen as a short seller in 2007/2008 as short positions he held in MBIA (NYSE: MBI) and Ambac (NYSE: ABK) proved to be big winners due to the credit crunch.
In July 2008, Ackman said he was short the common stock of Fannie Mae (NYSE: FNM) and Freddie Mac (NYSE: FRE). Ackman also laid out a plan to reorganize the GSEs, which would wipe out the common shareholders.
View Older Stories View More Recent Stories
-
Pershing Square Valeant Pharma (VRX) Conf. Call Up and Running after Technical Difficulties
-
Valeant Pharma (VRX) on Watch as Ahead of Pershing Square Conference Call
-
I Hope Bill Ackman Has Done More Research on Valeant (VRX) Than Herbalife: Herbalife (HLF)
-
Herbalife Issues Statement Regarding Bill Ackman’s Presentation
-
William Green, Author Great Minds of Investing, Talks with Sarder TV About his Career as a Writer & Journalist
-
Valeant says Philidor pharmacy shutting down as it cuts ties
-
CVS, Express Scripts drop Valeant's Philidor; stock dives
-
Ackman's Pershing Square Down 15.9% YTD
-
ValueAct rallies Valeant investors as company fends off attack: source
-
Ackman to hold call to discuss investment in Valeant
-
Ackman's Pershing Square to Hold Conf. Call About Valeant Pharma (VRX) Investment
-
Pershing Square Holdings, Ltd. Announces Investor Call to Discuss its Investment in Valeant Pharmaceuticals International, Inc.
-
Short interest piled on Valeant ahead of scathing report
-
WPP Third Quarter Trading Update
-
Valeant slump poses big threat to small hedge funds
-
Valeant vows to refute 'phantom sales' allegations
-
Pershing Square's Ackman Down ~40% on Valeant Pharma (VRX) Bet
-
Ackman Affirms Buying Another 2M Valeant Pharma (VRX) Shares; Hasn't Sold Any - Bloomberg
-
UPDATE: Ackman Bought 2M More Shares of Valeant Pharma (VRX) - CNBC
-
Valeant meltdown costs investors billions; Ackman ups stake
-
Valeant shares plunge on short-seller scrutiny of pharmacy revenue
-
Hedge Funds on Edge as Valeant Pharma (VRX) Sinks
-
Wall St. declines; Valeant, healthcare weigh
-
Hedge funds suffer biggest quarterly drop in assets since 2008: data
-
EMC-Dell talks highlight Elliott's clout across tech sector
-
Hedge funds posted fourth month of declines in September: HFR data
-
Herbalife shares slump on Nu Skin, Ackman's 'new' information
-
Ackman's Pershing Square Holdings Up 1.6% So Far in October
-
Pershing Square Holdings, Ltd. Releases Regular Weekly Net Asset Value as of October 6 2015, and Announces Third Quarter 2015 Investor Call
-
Shawn Baldwin, Chairman of AIA Group, Joins Top Investors at Bloomberg Markets Most Influential Summit in New York
-
Herbalife (HLF) Weakness May be Tied to Recent Ackman Comments
-
Bill Ackman says short-term money driving market volatility
-
Bill Ackman Thinks Michael Bloomberg Could Announce Presidential Bid... and Win
-
Arkansas teachers top off a sweet day for Peltz' Trian hedge fund
-
U.S. hedge funds brace for worst year since financial crisis
-
Exclusive - Mondelez seeks European cheese and grocery asset sale: sources
-
The Pershing Square Sohn Cancer Research Alliance Now Accepting Applications for the 2016 Prize for Young Investigators in Cancer Research
-
CTBC Bank USA CEO Noor Menai to Speak at Bloomberg Markets Most Influential Summit
-
CTBC Bank USA CEO Noor Menai to Speak at Bloomberg Markets Most Influential Summit
-
Democrats take aim at drug prices, prompting sharp drops in biotech stocks
-
Market Wrap: Industrial Production Slumps in August; H-P Sees Big Job Cuts; Major Dental Supply Merger Announced
-
Sysco targets $400 million in annual operating income growth by 2018
-
Ackman's Pershing Square Details Similarities Between Herbalife (HLF) and MLM Company Vemma
-
Bill Ackman, Barry Diller, Blythe Masters and Roger Ferguson Headline 5th Annual Bloomberg Markets Most Influential Summit
-
Carl Icahn Goes After Jim Chanos' Jugular in Cheniere Energy (LNG)
-
On Sale: Buy This 'Internet of Things' Stock Cheaper Than This Bill Ackman Protege
-
John Paulson's fund losses in August dent strong start to year
-
Exclusive: Peltz's Trian fund suffers brutal August decline
-
FTC Takes Aim at Former Vemma, Herbalife (HLF) Top Distributor
-
Mondelez to boost ad spending, healthier offerings

